[{"Assets_0_Q2_USD":148105000.0,"CommonStockSharesOutstanding_0_Q2_shares":24967603.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-12992000.0,"NetIncomeLoss_1_Q2_USD":-29174000.0,"NetIncomeLoss_2_Q2_USD":-43277000.0,"StockholdersEquity_0_Q2_USD":84316000.0,"Ticker":"PTGX","CIK":"1377121","name":"PROTAGONIST THERAPEUTICS, INC","OfficialName":"Protagonist Therapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"939483174.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190807"}]